Abstract
The increasing prevalence of multidrug-resistant pathogens necessitates the urgent development of new antimicrobial agents with innovative modes of action for the next generation of antimicrobial therapy.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have